Treatt PLC (TET)

Industry Specialty Chemicals


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

258.50p

Buy

260.50p

arrow-down-11.437p (-4.21%)

Prices updated at 13 May 2025, 14:12 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Treatt PLC is engaged in manufacture and supply of ingredient solutions for the flavor, fragrance and FMCG markets.
Sector
Basic Materials
Industry
Specialty Chemicals
Chairman
Mr. Vijay Champaklal Thakrar
CEO
Mr. David Shannon
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
381
Head office
Skyliner Way
Bury St. Edmunds
United Kingdom
IP32 7FR
mobile
+44 1284702500
letter
cosec@treatt.com

Key personnel

Salary
Mr. Philip O'Connor
Non-Executive Director, Senior Independent Director
-
Mr. Vijay Champaklal Thakrar
Non-Executive Director, Chairman
-
Ms. Bronagh Kennedy
Non-Executive Director
-
Mr. Ryan Govender
Executive Director, Chief Financial Officer, Company Secretary and Managing Director, Europe
-
Mr. David Shannon
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
BlackRock Investment Management (UK) Ltd.2,701,270
BlackRock Smaller Companies2,522,114
Liontrust Fund Partners LLP2,515,093
Liontrust UK Ethical Fund2,515,093
abrdn UK Smaller Companies Fund1,903,214

Director dealings

Action
17 Mar 2025D
17 Mar 2025D
13 Dec 2024Transfer in
13 Dec 2024Purchase
13 Dec 2024Purchase
13 Dec 2024Transfer in
23 Sep 2024Purchase
15 Aug 2024D
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.